Learn More
Hyponatremia is frequently observed on the basis of syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH) in patients suffering from lung cancer. This electrolyte imbalance is associated with higher mortality and morbidity. If hyponatremia influences survival of lung cancer remains controversial. In the current study we retrospectively(More)
BACKGROUND Hyponatremia based on syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH) is observed in up to 15% of patients with small cell lung cancer (SCLC). The electrolyte imbalance is associated with a high morbidity and mortality and often delays appropriate treatment. Management of hyponatremia proved to be challenging until new(More)
The treatment and medical care of patients with lung cancer is mostly characterised and complicated by a reduced life expectancy. The lack of time can easily be the cause for various problems concerning the handling of these patients, their relatives and medical staff. A concept for opening future perspectives through standardised steps of communication(More)
Over the last years, several new systemic cancer therapy strategies have been introduced to turn the growing insights of molecular aberrations involved in the development and progression of lung cancer into better treatment options fort the patients. This review presents some of the most important biological targets and biomarkers relevant in the treatment(More)
This is a small uncontrolled study in a single centre that describes 10 cases of SCLC HN accumularted over an 18 month period managed by a trial algorithm that defines mild moderate and severe HN differently depending on whether persistent or acute/recurrent and presents no aggretaed data to support the claims of clinical utility of tolvaptan in this(More)
We present a case of a 54-year-old woman who was diagnosed with a KRAS positive adenocarcinoma of the lung on the basis of a Peutz-Jeghers syndrome (PJS), which was unknown before. PJS is a rare hereditary disease, which may be associated with the development of poor outcome adenocarcinomas and LKB1-gene mutations. A very rare type of a LKB1 mutation was(More)
  • 1